| CLASS | ABXBACT | LP7755-4 |
| COMPONENT | Zalcitabine | LP21316-2 |
| PROPERTY | Susc | LP6870-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Isolate | LP7370-2 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | Genotyping | LP28723-2 |
| parent | Zalcitabine | Isolate | Antibiotic susceptibilities | LP380365-9 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Observation | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | Zalcitabine [Susceptibility] by Genotype method |
| LONG_COMMON_NAME | en-US | Zalcitabine [Susceptibility] by Genotype method |
| SHORTNAME | en-US | Zalcitabine Islt Genotyp |
| ConsumerName | en-US | Susceptibility to Zalcitabine |
| SHORTNAME | es-AR | zalcitabina:susceptibilidad:punto en el tiempo:cepa clínica:ordinal o cuantitativo:genotipificación |
| SHORTNAME | pt-BR | Zalcitabine Islt Genotyp |
| LONG_COMMON_NAME | fr-FR | Zalcitabine [Sensibilité] Isolat ; Qualitatif ; Génotypage |
| LONG_COMMON_NAME | nl-NL | Zalcitabine [gevoeligheid] in isolaat d.m.v. genotypering |
| LONG_COMMON_NAME | es-MX | Zalcitabina: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal: Susceptibilidad del genotipo viral |
LOINC Version: 2.77
FHIR